477 related articles for article (PubMed ID: 26915027)
1. Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.
Hsu DC; Sereti I
Drugs; 2016 Apr; 76(5):533-49. PubMed ID: 26915027
[TBL] [Abstract][Full Text] [Related]
2. Serious Non-AIDS events: Immunopathogenesis and interventional strategies.
Hsu DC; Sereti I; Ananworanich J
AIDS Res Ther; 2013 Dec; 10(1):29. PubMed ID: 24330529
[TBL] [Abstract][Full Text] [Related]
3. Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART.
Zicari S; Sessa L; Cotugno N; Ruggiero A; Morrocchi E; Concato C; Rocca S; Zangari P; Manno EC; Palma P
Viruses; 2019 Feb; 11(3):. PubMed ID: 30818749
[TBL] [Abstract][Full Text] [Related]
4. HIV and inflammation: mechanisms and consequences.
Hunt PW
Curr HIV/AIDS Rep; 2012 Jun; 9(2):139-47. PubMed ID: 22528766
[TBL] [Abstract][Full Text] [Related]
5. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.
Gunda DW; Kilonzo SB; Kamugisha E; Rauya EZ; Mpondo BC
BMC Res Notes; 2017 Jun; 10(1):197. PubMed ID: 28595630
[TBL] [Abstract][Full Text] [Related]
7. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
8. Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.
Hunt PW; Lee SA; Siedner MJ
J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S44-50. PubMed ID: 27625430
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
10. Residual immune dysregulation syndrome in treated HIV infection.
Lederman MM; Funderburg NT; Sekaly RP; Klatt NR; Hunt PW
Adv Immunol; 2013; 119():51-83. PubMed ID: 23886064
[TBL] [Abstract][Full Text] [Related]
11. Managing HIV-associated inflammation and ageing in the era of modern ART.
Bloch M; John M; Smith D; Rasmussen TA; Wright E
HIV Med; 2020 Oct; 21 Suppl 3():2-16. PubMed ID: 33022087
[TBL] [Abstract][Full Text] [Related]
12. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
13. [Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].
Rubio R; Berenguer J; Miró JM; Antela A; Iribarren JA; González J; Guerra L; Moreno S; Arrizabalaga J; Clotet B; Gatell JM; Laguna F; Martínez E; Parras F; Santamaría JM; Tuset M; Viciana P
Enferm Infecc Microbiol Clin; 2002; 20(6):244-303. PubMed ID: 12084354
[TBL] [Abstract][Full Text] [Related]
14. Inflammation, Immune Activation, and Antiretroviral Therapy in HIV.
Hileman CO; Funderburg NT
Curr HIV/AIDS Rep; 2017 Jun; 14(3):93-100. PubMed ID: 28434169
[TBL] [Abstract][Full Text] [Related]
15. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
Freeman ML; Lederman MM; Gianella S
Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
[TBL] [Abstract][Full Text] [Related]
16. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
17. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
[TBL] [Abstract][Full Text] [Related]
18. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
[TBL] [Abstract][Full Text] [Related]
19. Deciphering natural control of HIV-1: A valuable strategy to achieve antiretroviral therapy termination.
Loucif H; Gouard S; Dagenais-Lussier X; Murira A; Stäger S; Tremblay C; Van Grevenynghe J
Cytokine Growth Factor Rev; 2018 Apr; 40():90-98. PubMed ID: 29778137
[TBL] [Abstract][Full Text] [Related]
20. Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage.
Rajasuriar R; Wright E; Lewin SR
Curr Opin HIV AIDS; 2015 Jan; 10(1):35-42. PubMed ID: 25415420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]